Long-Term Outcomes of Left Atrial Appendage Closure in Atrial Fibrillation Patients Unsuitable for Oral Anticoagulation: Insights from the ASAP-TOO Trial

Highlight

  • ASAP-TOO evaluated left atrial appendage closure (LAAC) for patients with atrial fibrillation (AF) unsuitable for oral anticoagulation (OAC).
  • LAAC implantation success was high (97.8%) with low periprocedural complications.
  • Over 5 years, ischemic stroke or systemic embolism rates trended lower with LAAC but were not statistically significant due to early trial termination and underpowering.
  • Major bleeding was numerically higher in the LAAC group, primarily during the first 3 months due to mandated antiplatelet therapy.

Study Background

Specialty calculators

Browse calculators

For clinical reference; use professional judgment.

Comments

No comments yet. Why don’t you start the discussion?

Leave a Reply